metformin and dinoprost

metformin has been researched along with dinoprost in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (21.43)29.6817
2010's10 (71.43)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Belgorosky, D; Elia, EM; Faut, M; Luigi, D; Motta, AB; Pustovrh, C; Vighi, S1
Facorro, GB; Motta, AB; Piehl, L; Rubín de Celis, E; Sander, VA1
Colette, C; Cristol, JP; Michel, F; Monnier, L; Owens, DR1
Benarroch, M; Gornitsky, M; Salah, MH; Schipper, HM; Su, H; Trifiro, M; Velly, AM1
Lee, IT; Lee, WJ; Lin, SD; Lin, SY; Sheu, WH; Su, SL; Tseng, YH; Tu, ST; Wang, JS1
Hou, WK; Huang, QX; Li, MZ; Lin, P; Liu, Q; Song, J; Wang, K; Wang, Q; Xu, H; Yu, S; Zhang, L; Zhang, Y1
Crea, F; Di Franco, A; Ghirlanda, G; Lanza, GA; Manto, A; Milo, M; Nerla, R; Pagliaccia, F; Pitocco, D; Rizzo, P; Rocca, B; Scavone, G; Tarzia, P; Zaccardi, F1
Aslan, I; Aslan, M; Tuzcu, H1
Poretsky, L; Striker, GE; Vlassara, H; Woodward, M; Yubero-Serrano, EM1
Nurifahmi, R; Sauriasari, R; Sekar, AP; Susilo, VY; Wulandari, F1
Hur, KY; Jin, SM; Kim, G; Kim, JH; Lee, MK; Oh, S1
Andreadou, I; Dimopoulos, MA; Doerschmann, H; Efentakis, P; Kastritis, E; Nikolaou, PE; Siemer, S; Stauber, R; Terpos, E; Wenzel, P; Witzler, C1

Trials

5 trial(s) available for metformin and dinoprost

ArticleYear
Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Clinical therapeutics, 2011, Volume: 33, Issue:12

    Topics: Acarbose; Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dinoprost; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Lipoproteins, LDL; Male; Medication Adherence; Metformin; Middle Aged; Outpatients; Oxidative Stress; Regression Analysis; Taiwan; Time Factors; Treatment Outcome

2011
Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.
    Chinese medical journal, 2012, Volume: 125, Issue:19

    Topics: Apelin; Blood Glucose; Body Mass Index; Chemokines; Diabetes Mellitus, Type 2; Dinoprost; Humans; Hypoglycemic Agents; Inflammation; Intercellular Signaling Peptides and Proteins; Metformin; Pioglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2012
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.
    Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:5

    Topics: Adult; Biomarkers; Blood Glucose; Brachial Artery; Diabetes Mellitus, Type 1; Dinoprost; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Oxidative Stress; Pilot Projects; Treatment Outcome; Vasodilation

2013
Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
    Clinical journal of the American Society of Nephrology : CJASN, 2015, May-07, Volume: 10, Issue:5

    Topics: Adiponectin; Age Factors; Aged; Albuminuria; Chelating Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Estrogen Receptor alpha; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Intention to Treat Analysis; Lysine; Male; Metformin; Middle Aged; NF-E2-Related Factor 2; Pyruvaldehyde; Receptor for Advanced Glycation End Products; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Sevelamer; Sex Factors; Single-Blind Method; Sirtuin 1; White People

2015
The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus.
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:12

    Topics: Adamantane; Blood Glucose; Diabetes Mellitus, Type 2; Dinoprost; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nitriles; Pyrrolidines; Sulfonylurea Compounds; Treatment Outcome; Vildagliptin

2017

Other Studies

9 other study(ies) available for metformin and dinoprost

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice.
    Molecular human reproduction, 2009, Volume: 15, Issue:7

    Topics: Animals; Blotting, Western; Catalase; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclooxygenase 2; Dehydroepiandrosterone; Dinoprost; Enzyme Activation; Female; Flow Cytometry; In Vitro Techniques; Metformin; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase; Oxidative Stress; Polycystic Ovary Syndrome; Radioimmunoassay; Superoxide Dismutase; Uterus

2009
Effect of DHEA and metformin on corpus luteum in mice.
    Reproduction (Cambridge, England), 2009, Volume: 138, Issue:3

    Topics: Animals; Corpus Luteum; Dehydroepiandrosterone; Dinoprost; Female; Hyperandrogenism; Hypoglycemic Agents; Lipid Peroxidation; Metformin; Mice; Mice, Inbred BALB C; Ovary; Oxidative Stress; Pregnancy; Prostaglandins E

2009
Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study.
    Diabetes/metabolism research and reviews, 2011, Volume: 27, Issue:4

    Topics: Aged; Body Mass Index; Caloric Restriction; Diabetes Mellitus, Type 2; Dinoprost; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Oxidative Stress; Reproducibility of Results; Thiazolidinediones

2011
Altered redox homeostasis in human diabetes saliva.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2012, Volume: 41, Issue:3

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Age Factors; Biomarkers; Deoxyguanosine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet, Diabetic; Dinoprost; DNA Damage; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Metformin; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Saliva; Salivary Proteins and Peptides; Sex Factors

2012
The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients.
    Oxidative medicine and cellular longevity, 2013, Volume: 2013

    Topics: Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dinoprost; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Insulin; Lipid Peroxidation; Male; Metformin; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Protein Carbonylation; Sulfonylurea Compounds; Tyrosine

2013
The Correlation Between Urinary 8-Iso-Prostaglandin F2α and Hydrogen Peroxide Toward Renal Function in T2DM Patients Consuming Sulfonylurea and Combination of Metformin-Sulfonylurea.
    Current diabetes reviews, 2018, Volume: 14, Issue:2

    Topics: Aged; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Female; Glomerular Filtration Rate; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Linear Models; Male; Metformin; Middle Aged; Oxidative Stress; Sulfonylurea Compounds

2018
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib.
    International journal of molecular sciences, 2020, Jul-22, Volume: 21, Issue:15

    Topics: Actins; AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents; Autophagy; Cell Survival; Cobalt; Dinoprost; Drug Therapy, Combination; Endoplasmic Reticulum; Glucose; Glycolysis; Humans; Male; Metformin; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Nitric Oxide; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Kinases; Reactive Oxygen Species; Tumor Suppressor Protein p53

2020
chemdatabank.com